Biltricide

DRUG2 trials

Sponsors

Merck KGaA, Darmstadt, Germany, Merck KGaA

Conditions

HealthyS. mansoni and S. haematobium

Phase 1

Praziquantel Bioequivalence Study

CompletedNCT03437447

Merck KGaA, Darmstadt, GermanyHealthy

Start: 2018-06-18End: 2018-07-06Updated: 2019-09-18

Phase 3

Phase III pediatric study with the L-PZQ ODTs

Active, not recruitingPACTR201810634034543

Merck KGaAS. mansoni and S. haematobium

Start: 2019-05-20Target: 311Updated: 2026-08-03